193 related articles for article (PubMed ID: 37580918)
21. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
22. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
23. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
Abdel-Latif MM; Abdel-Wahab BA
Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
[TBL] [Abstract][Full Text] [Related]
24. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
[TBL] [Abstract][Full Text] [Related]
26. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
[TBL] [Abstract][Full Text] [Related]
27. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
[TBL] [Abstract][Full Text] [Related]
28. Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists.
Lemay J; Alsaleh FM; Al-Buresli L; Al-Mutairi M; Abahussain EA; Bayoud T
Med Princ Pract; 2018; 27(1):30-38. PubMed ID: 29402876
[TBL] [Abstract][Full Text] [Related]
29. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
Santosh KC; Tragulpiankit P; Edwards IR; Gorsanan S
Int J Risk Saf Med; 2013 Jan; 25(1):1-16. PubMed ID: 23442293
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study.
Ahmad A; Patel I; Balkrishnan R; Mohanta GP; Manna PK
Perspect Clin Res; 2013 Oct; 4(4):204-10. PubMed ID: 24312887
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
[TBL] [Abstract][Full Text] [Related]
32. Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.
Almandil NB
Saudi Med J; 2016 Dec; 37(12):1359-1364. PubMed ID: 27874152
[TBL] [Abstract][Full Text] [Related]
33. Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?
Ibrahim DM; Shawki MA; Solayman MH; Sabri NA
Int J Clin Pract; 2021 Nov; 75(11):e14731. PubMed ID: 34387008
[TBL] [Abstract][Full Text] [Related]
34. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
Adenuga BA; Kibuule D; Rennie TW
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
[TBL] [Abstract][Full Text] [Related]
35. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India.
Gupta SK; Nayak RP; Shivaranjani R; Vidyarthi SK
Perspect Clin Res; 2015; 6(1):45-52. PubMed ID: 25657902
[TBL] [Abstract][Full Text] [Related]
36. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
[TBL] [Abstract][Full Text] [Related]
37. Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review.
Balan S
Int J Pharm Pract; 2021 Aug; 29(4):308-320. PubMed ID: 34289016
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
39. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
Mulchandani R; Kakkar AK
Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
[TBL] [Abstract][Full Text] [Related]
40. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey.
Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C
Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
